APRI Market Cap History
Below is a table of the APRI market cap history going back to 10/24/2016:

Date APRI Market Cap
10/24/201618.47M
10/31/201615.54M
3/7/201721.44M
5/4/201714.82M
7/28/201716.36M
10/27/201725.41M
2/26/201815.85M
4/27/20186.33M
8/6/20186.80M
10/29/20189.01M

Also see: APRI Shares Outstanding History
and APRI YTD Return
APRI Historical Market Cap:
-29.98% CAGR
APRI Historical Market Cap: +-29.98% CAGR

Mouse over chart for data details
10/24/201610/31/20163/7/20175/4/20177/28/201710/27/20172/26/20184/27/20188/6/201810/29/2018
Seelos Therapeutics is a biopharmaceutical company focused on the development of product candidates in the areas of urology and rheumatology. Co. has two product candidates : Vitaros, a topically-applied cream formulation of alprostadil for the treatment of erectile dysfunction, which Co. in-licensed from Warner Chilcott Company, Inc.; and RayVa, a topically-applied cream formulation of alprostadil designed to dilate blood vessels for the treatment of Raynaud's Phenomenon, secondary to scleroderma, for which it owns worldwide rights. We show 10 historical shares outstanding datapoints in our APRI shares outstanding history coverage, used to compute APRI market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing APRI market cap history over the course of time is important for investors interested in comparing APRI's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of APRI versus a peer is one thing; comparing APRI market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like APRI can fluctuate over the course of history. With this page we aim to empower investors researching APRI by allowing them to research the APRI market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for APRI:
APRI SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Apricus Biosciences (APRI) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

APVO Market Cap History
AQB Market Cap History
AQXP Market Cap History
ARA Market Cap History
ARAY Market Cap History
ARDM Market Cap History
ARDX Market Cap History
ARNA Market Cap History
ARQL Market Cap History
ARRY Market Cap History
More Healthcare companies »

 

APRI Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.